Lincoln Pharmaceuticals Announces Final Dividend Recommendation for FY26
Lincoln Pharmaceuticals (NSE/BSE: LINCOLN) has recommended a final dividend of Rs 1.80 per equity share for the financial year ended March 31, 2026. The proposed payout translates to an 18% return on the face value of Rs 10 per share, subject to approval from shareholders at the company's upcoming Annual General Meeting.
The announcement aligns with Lincoln Pharma's consistent practice of returning value to shareholders through dividend distributions. The company has maintained a steady dividend policy, reflecting its commitment to reward investors while preserving sufficient capital for operational growth and strategic initiatives.
Key Dividend Details
- Dividend per share: Rs 1.80
- Dividend rate: 18% on face value
- Face value per share: Rs 10
- Financial year: FY26 (ended March 31, 2026)
- Approval required: Shareholders at AGM
What This Means for Shareholders
If approved at the AGM, shareholders holding Lincoln Pharmaceuticals shares as on the record date will be eligible to receive the dividend. Investors are advised to monitor official company communications for updates on the record date and AGM schedule, which will determine the eligibility timeline for receiving the payout.
The recommended dividend demonstrates the company's financial health and ability to generate consistent cash flows. Lincoln Pharma's performance in the domestic formulations market has contributed to its profitability, enabling such distributions to equity holders.
AGM Approval Process
The final dividend recommendation is subject to approval by members at the ensuing Annual General Meeting. This is a standard corporate governance practice ensuring shareholders have a say in major capital allocation decisions. Once the AGM date is announced, shareholders can review the official notice containing detailed agenda items and financial statements before casting their votes.
Investors tracking Lincoln Pharmaceuticals on BSE or NSE should stay updated through corporate filings and exchange announcements for the exact AGM date and record date details. The dividend will be dispatched to eligible shareholders following the AGM approval and within the regulatory timeline prescribed under the Companies Act.
About Lincoln Pharmaceuticals
Lincoln Pharmaceuticals operates in the pharmaceutical formulations segment, primarily serving the domestic Indian market. The company manufactures a diverse portfolio of products across therapeutic segments including anti-infectives, cardiovascular, gastrointestinal, and dermatology. Its manufacturing facilities support production for both domestic and export markets, contributing to revenue diversification.
Track Corporate Actions on ztox.in
Stay informed about Lincoln Pharmaceuticals and other NSE/BSE listed companies through ztox.in's corporate actions coverage. The platform tracks dividend announcements, stock splits, bonus issues, and AGM updates across Indian equity markets.
Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions.